Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,299 | 37 | 92.2% |
| Education | $109.93 | 2 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $291.46 | 7 | $0 (2024) |
| Nevro Corp. | $219.19 | 2 | $0 (2019) |
| UCB, Inc. | $218.04 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $180.05 | 6 | $0 (2024) |
| Lilly USA, LLC | $87.31 | 4 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $63.68 | 3 | $0 (2024) |
| PFIZER INC. | $60.02 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $58.68 | 2 | $0 (2018) |
| Incyte Corporation | $47.19 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $36.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $766.28 | 22 | UCB, Inc. ($218.04) |
| 2023 | $140.26 | 2 | ABBVIE INC. ($124.99) |
| 2021 | $26.15 | 1 | AbbVie Inc. ($26.15) |
| 2020 | $42.74 | 2 | AbbVie Inc. ($22.32) |
| 2019 | $289.54 | 6 | Nevro Corp. ($198.62) |
| 2018 | $77.96 | 3 | Janssen Pharmaceuticals, Inc ($28.27) |
| 2017 | $65.79 | 3 | Janssen Biotech, Inc. ($32.53) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $27.66 | General |
| 10/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.90 | General |
| Category: Dermatology | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $94.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Immunology | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $36.09 | General |
| Category: Immunology | ||||||
| 08/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: DERMATOLOGY | ||||||
| 08/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: DERMATOLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA, ARAZLO | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Dermatology | ||||||
| 05/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.29 | General |
| Category: Dermatology | ||||||
| 04/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: DERMATOLOGY | ||||||
| 03/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: DERMATOLOGY | ||||||
| 01/08/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $166.66 | General |
| Category: Immunology | ||||||
| 04/10/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 03/02/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,437 | 2,180 | $558,027 | $162,127 |
| 2022 | 12 | 1,476 | 2,163 | $531,303 | $155,000 |
| 2021 | 14 | 1,626 | 2,401 | $553,184 | $172,228 |
| 2020 | 18 | 1,465 | 2,235 | $484,423 | $138,796 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 463 | 629 | $228,956 | $66,323 | 29.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 182 | 217 | $59,572 | $24,504 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 280 | 332 | $82,004 | $24,466 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 110 | 110 | $40,150 | $9,085 | 22.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 131 | 165 | $33,075 | $8,792 | 26.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 89 | 93 | $31,620 | $8,294 | 26.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 37 | $26,696 | $6,095 | 22.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 19 | 19 | $24,390 | $5,583 | 22.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 100 | 539 | $11,319 | $3,871 | 34.2% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 15 | $8,125 | $1,912 | 23.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $7,406 | $1,787 | 24.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $4,715 | $1,415 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 384 | 509 | $179,677 | $50,503 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 343 | 415 | $99,600 | $30,517 | 30.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 200 | 238 | $62,176 | $26,013 | 41.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 110 | 119 | $38,830 | $11,002 | 28.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 130 | 130 | $46,020 | $10,307 | 22.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 121 | 152 | $29,760 | $7,210 | 24.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 21 | 22 | $27,888 | $6,836 | 24.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 22 | 30 | $19,251 | $4,409 | 22.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 100 | 499 | $10,479 | $3,498 | 33.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 16 | 16 | $6,816 | $2,051 | 30.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 12 | 12 | $6,018 | $1,519 | 25.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 17 | 21 | $4,788 | $1,136 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 486 | 615 | $210,945 | $63,409 | 30.1% |
About Roger Lee, M D PHD
Roger Lee, M D PHD is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1538318704.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roger Lee, M D PHD has received a total of $1,409 in payments from pharmaceutical and medical device companies, with $766.28 received in 2024. These payments were reported across 39 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,299).
As a Medicare-enrolled provider, Lee has provided services to 6,004 Medicare beneficiaries, totaling 8,979 services with total Medicare billing of $628,151. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Palo Alto, CA
- Active Since 09/12/2008
- Last Updated 06/04/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1538318704
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $219.19
- Bimzelx (Biological) $218.04
- DUPIXENT (Biological) $167.36
- RINVOQ (Biological) $156.15
- SKYRIZI (Biological) $114.61
- TALTZ (Drug) $65.41
- OPZELURA (Drug) $47.19
- EUCRISA (Drug) $44.75
- SILIQ (Drug) $42.76
- Sotyktu (Drug) $36.09
- GUSELKUMAB (Biological) $32.53
- Otezla (Drug) $30.50
- INVOKANA (Drug) $28.27
- VTAMA (Drug) $26.51
- Tremfya (Drug) $26.15
- OLUMIANT (Drug) $21.90
- Cabtreo (Drug) $20.92
- Humira (Biological) $20.70
- COSENTYX (Biological) $20.42
- CIBINQO (Drug) $15.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dr. Daniel Navi, M.d, M.D
Dermatology — Payments: $19,065
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860